US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
NeuBase Therapeutics Inc (NBSE)
NeuBase Therapeutics Inc (NBSE) ニュース

NBSE

NeuBase Therapeutics (NBSE)

NeuBase Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:NBSE

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/23	05 : 59	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NBSE	NeuBase Therapeutics Inc
2024/05/16	23 : 07	Edgar (US Regulatory)	Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities	NASDAQ:NBSE	NeuBase Therapeutics Inc
2024/05/14	05 : 25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NBSE	NeuBase Therapeutics Inc
2024/05/06	20 : 30	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:NBSE	NeuBase Therapeutics Inc
2024/04/06	05 : 05	GlobeNewswire Inc.	NeuBase Therapeutics Announces Receipt of Notice from Nasdaq	NASDAQ:NBSE	NeuBase Therapeutics Inc
2024/03/08	06 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NBSE	NeuBase Therapeutics Inc
2024/02/24	06 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NBSE	NeuBase Therapeutics Inc
2024/01/26	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NBSE	NeuBase Therapeutics Inc
2024/01/17	20 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/12/28	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/12/28	20 : 15	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/12/22	20 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/11/27	23 : 00	GlobeNewswire Inc.	Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/11/10	06 : 11	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/11/07	07 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/11/07	07 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/10/20	20 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/10/18	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/09/30	05 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/09/21	09 : 42	Edgar (US Regulatory)	Form 5 - Annual statement of changes in beneficial ownership of securities	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/09/21	06 : 28	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/09/19	05 : 32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/09/19	05 : 20	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/09/19	05 : 17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/09/14	19 : 03	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/09/13	06 : 20	Edgar (US Regulatory)	Form 3/A - Initial statement of beneficial ownership of securities: [Amend]	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/09/12	06 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/09/08	20 : 00	GlobeNewswire Inc.	NeuBase Therapeutics Issues Statement Regarding Filing By Shareholder	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/09/08	06 : 19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/09/06	23 : 00	PR Newswire (US)	SYMETRYX CORPORATION ACQUIRES 20% STOCK IN NEUBASE	NASDAQ:NBSE	NeuBase Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:NBSE

1 2 3 4 5 6 次へ >>

Adventus Mining

Burzynski Research Insti... (PK)

Intelbras S.A ON

BPCE Bond Matures 27jun2...

Kospi 200 ETN 91

Matador Resources

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約